Does FRUQUINTINIB Cause Neoplasm malignant? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Neoplasm malignant have been filed in association with FRUQUINTINIB (Fruzaqla). This represents 0.5% of all adverse event reports for FRUQUINTINIB.
12
Reports of Neoplasm malignant with FRUQUINTINIB
0.5%
of all FRUQUINTINIB reports
9
Deaths
2
Hospitalizations
How Dangerous Is Neoplasm malignant From FRUQUINTINIB?
Of the 12 reports, 9 (75.0%) resulted in death, 2 (16.7%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FRUQUINTINIB. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does FRUQUINTINIB Cause?
Death (647)
Fatigue (366)
Colon cancer (277)
Blood pressure increased (223)
Diarrhoea (213)
Colorectal cancer metastatic (212)
Decreased appetite (184)
Asthenia (178)
Dysphonia (176)
Off label use (133)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which FRUQUINTINIB Alternatives Have Lower Neoplasm malignant Risk?
FRUQUINTINIB vs FULVESTRANT
FRUQUINTINIB vs FURAZOLIDONE
FRUQUINTINIB vs FUROSEMIDE
FRUQUINTINIB vs FUROSEMIDE\SPIRONOLACTONE
FRUQUINTINIB vs FUSIDATE